Tax-Inversion Rules Don’t Kill Pfizer-Allergan Hopes

By | November 20, 2015

Scalper1 News

Shares of drug giants Pfizer (PFE) and Allergan (AGN) were both up Friday as analysts said new U.S. Treasury guidelines on tax-inversion deals shouldn’t hinder the two companies’ possible merger. New York-based Pfizer has been in talks with Ireland-based Allergan since late last month about the possibility of a buyout that would allow Pfizer to relocate to Allergan’s lower-tax home. Wall Street generally approved of the idea, but on Thursday both Scalper1 News

Scalper1 News